Information Center

02 Feb,2024

Among substances that are both food and medicine, which one reigns supreme as a raw material for health foods? Includes efficacy and recommended dosage.

With the conclusion of the pilot program for nine substances, including Codonopsis pilosula, the list of food‑medicine homologous substances has expanded to 102. Drawing on a contribution from forum user “Hancǎo” and referencing Fan Qingsheng’s book “Principles and Rationale of Health Food Formulations,” these food‑medicine homologous ingredients have been categorized according to the functional claims typically associated with health foods, providing a convenient reference for researchers and developers in the health food industry.

28 Jan,2024

Strengthening Enterprises with Courtesy, Advancing Together with Beauty

To enhance the company’s meeting and hospitality standards, elevate employees’ overall competencies, and strengthen the corporate brand image, Zhejiang Wanglin Biotechnology Co., Ltd. organized a specialized training session on January 27, themed “Reception and Business Etiquette.” The company invited Ms. Xia Manhui, Chief Training Instructor at Xianyun Body‑Shape, to deliver the course.

08 Jan,2024

Announcement on the Publication of the Catalogue of Raw Materials for Three Health Food Products, Including Ginseng

In accordance with the Food Safety Law of the People’s Republic of China, the Measures for the Administration of the Catalogue of Health Food Raw Materials and the Catalogue of Health Functions, and other relevant provisions, the State Administration for Market Regulation, in conjunction with the National Health Commission and the State Administration of Traditional Chinese Medicine, has formulated the “Catalogue of Health Food Raw Materials: Ginseng,” the “Catalogue of Health Food Raw Materials: American Ginseng,” and the “Catalogue of Health Food Raw Materials: Ganoderma,” which are hereby promulgated and shall take effect as of May 1, 2024.

21 Nov,2023

The first postdoctoral fellow at the Postdoctoral Research Station of Zhejiang Wanglin Biotechnology Co., Ltd. has completed their station tenure.

On November 20, the Postdoctoral Workstation of Zhejiang Wanglin Biotechnology Co., Ltd. held the exit defense for Dr. Qian Shaoping.

17 Nov,2023

Nine additional Chinese medicinal materials have been designated as substances with both medicinal and food uses.

Nine additional Chinese medicinal materials have been designated as having both food and medicinal properties. Codonopsis pilosula, Cistanche deserticola, Dendrobium officinale, American ginseng, Astragalus membranaceus, Ganoderma lucidum, Ophiopogon japonicus, Gastrodia elata, and Eucommia ulmoides leaves.

16 Nov,2023

Zhejiang Wanglin Bio has, for the first time, been listed among the “Top 500 National High-Tech Enterprises in Zhejiang Province for Innovation Capability” in 2023.

Zhejiang Wanglin Bio has, for the first time, made it onto the “2023 Top 500 High-Tech Enterprises in Zhejiang by Innovation Capability” list, ranking 493rd. Wanglin Bio will continue to ramp up its R&D investment, deepen its expertise in niche markets, and strive to become a small yet distinguished, specialized, and innovative enterprise.

< 1...789...24 >

Zhejiang Wanglin Bio-Tech Co., Ltd.

QQ: 2030074705

Mobile/WeChat: 13967006292

Phone: 0570-4322301

Email: hongcai.cheng@wanglin-bio.com

Address: No. 99, Nanjiao, Hongxing Village, Dachen Township, Jiangshan City, Zhejiang Province

Copyright © 2026 Zhejiang Wanglin Bio-Tech Co., Ltd.

Email Login

Business license

Powered by:CEglobal